Market Overview

PAVmed Inc. to Hold Business Update Conference Call on November 16th


PAVmed Inc. (NASDAQ:PAVM, PAVMW)), a highly differentiated,
multi-product medical device company, today announced that the Company
will host a conference call on Thursday, November 16, 2017 at 4:30 p.m.
Eastern time. During this call Lishan Aklog, M.D., the Company's
Chairman and Chief Executive Officer, will provide a business update
including an overview of the Company's near-term milestones and growth
strategy. In addition, Dennis McGrath, the Company's Chief Financial
Officer, will discuss third quarter 2017 financial results.

To access the conference call, U.S.-based listeners should dial (888)
803-5993 and international listeners should dial (706) 634-5454. All
listeners should provide the following passcode: 8082249. Individuals
interested in listening to the live conference call via the internet may
do so by visiting the Company's website at

Following the conclusion of the conference call, a replay will be
available through November 22, 2017 and can be accessed by dialing (855)
859-2056 from within the U.S. or (404) 537-3406 from outside the U.S.
All listeners should provide passcode: 8082249. The webcast will be
available for a period of time on the Company's website at

About PAVmed Inc.

PAVmed Inc. (NASDAQ:PAVM, PAVMW)) is a highly differentiated,
multi-product medical device company employing a unique business model
designed to advance products from concept to commercialization much more
rapidly and with significantly less capital than the typical medical
device company. This proprietary model enables PAVmed to pursue an
expanding multi-product pipeline strategy with a view to enhancing and
accelerating value creation. PAVmed's diversified pipeline of products
address unmet clinical needs, have attractive regulatory pathways and
market opportunities and encompass a broad spectrum of clinical areas
including carpal tunnel syndrome (CarpX™), medical infusions (NextFlo™
and NextCath™), interventional radiology (PortIO™ and NextCath), tissue
ablation and cardiovascular intervention (Caldus™) and pediatric ear
infections (DisappEAR™).

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at